PL2212324T3 - Związki posiadające właściwości przeciwwirusowe - Google Patents

Związki posiadające właściwości przeciwwirusowe

Info

Publication number
PL2212324T3
PL2212324T3 PL09771849T PL09771849T PL2212324T3 PL 2212324 T3 PL2212324 T3 PL 2212324T3 PL 09771849 T PL09771849 T PL 09771849T PL 09771849 T PL09771849 T PL 09771849T PL 2212324 T3 PL2212324 T3 PL 2212324T3
Authority
PL
Poland
Prior art keywords
compounds
antiviral properties
antiviral
properties
Prior art date
Application number
PL09771849T
Other languages
English (en)
Inventor
John Joseph Deadman
Eric Dale Jones
Giang Thanh Le
David Ian Rhodes
Neeranat Thienthong
De Graff Nicholas Andrew Van
Lisa Jane Winfield
Original Assignee
Avexa Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008903407A external-priority patent/AU2008903407A0/en
Application filed by Avexa Ltd filed Critical Avexa Ltd
Publication of PL2212324T3 publication Critical patent/PL2212324T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL09771849T 2008-07-02 2009-07-02 Związki posiadające właściwości przeciwwirusowe PL2212324T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2008903407A AU2008903407A0 (en) 2008-07-02 Compounds having antiviral properties
US16193109P 2009-03-20 2009-03-20
PCT/AU2009/000858 WO2010000032A1 (en) 2008-07-02 2009-07-02 Compounds having antiviral properties
EP09771849.8A EP2212324B1 (en) 2008-07-02 2009-07-02 Compounds having antiviral properties

Publications (1)

Publication Number Publication Date
PL2212324T3 true PL2212324T3 (pl) 2014-11-28

Family

ID=41465417

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09771849T PL2212324T3 (pl) 2008-07-02 2009-07-02 Związki posiadające właściwości przeciwwirusowe

Country Status (14)

Country Link
US (2) US8318732B2 (pl)
EP (2) EP2759544A1 (pl)
JP (1) JP5535204B2 (pl)
CN (1) CN102143962B (pl)
AU (1) AU2009266421B2 (pl)
BR (1) BRPI0913934A2 (pl)
CA (1) CA2729663A1 (pl)
ES (1) ES2459046T3 (pl)
IL (1) IL210207A0 (pl)
MX (1) MX2011000149A (pl)
NZ (1) NZ590126A (pl)
PL (1) PL2212324T3 (pl)
SG (1) SG192452A1 (pl)
WO (1) WO2010000032A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2729649A1 (en) * 2008-07-02 2010-01-07 Avexa Limited Thiazopyrimidinones and uses thereof
FR2947272B1 (fr) * 2009-06-29 2014-09-26 Univ Paris Curie Utilisation d'arn interferents pour le traitement d'une infection par le vih
CA2789457A1 (en) * 2010-02-26 2011-09-01 Susumu Miyazaki 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor
US8846659B2 (en) * 2010-12-10 2014-09-30 Bristol-Myers Squibb Company HIV integrase inhibitors
EP3082820B1 (en) 2013-12-19 2022-07-20 PTC Therapeutics, Inc. Methods for modulating the amount of rna transcripts
MY176508A (en) * 2014-04-28 2020-08-12 Jiangsu Kanion Parmaceutical Co Ltd Anti-enterovirus 71 thiadiazolidine derivative
EP4249472A3 (en) 2015-05-30 2023-12-13 PTC Therapeutics, Inc. Methods for modulating rna splicing
IL294124B2 (en) 2015-12-10 2024-02-01 Ptc Therapeutics Inc Methods for treating huntington's disease
US20180096362A1 (en) * 2016-10-03 2018-04-05 Amy Ashley Kwan E-Commerce Marketplace and Platform for Facilitating Cross-Border Real Estate Transactions and Attendant Services
EA201991309A1 (ru) 2016-11-28 2019-11-29 Способы модуляции сплайсинга рнк
US11407753B2 (en) 2017-06-05 2022-08-09 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
KR20200017476A (ko) 2017-06-14 2020-02-18 피티씨 테라퓨틱스, 인크. Rna 스플라이싱의 변경 방법
US11382918B2 (en) 2017-06-28 2022-07-12 Ptc Therapeutics, Inc. Methods for treating Huntington's Disease
WO2019005993A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. METHODS OF TREATING HUNTINGTON'S DISEASE
MX2020009957A (es) 2018-03-27 2021-01-15 Ptc Therapeutics Inc Compuestos para el tratamiento de enfermedad de hungtinton.
PL3814357T3 (pl) 2018-06-27 2024-09-16 Ptc Therapeutics, Inc. Związki heterocykliczne i heteroarylowe do leczenia choroby huntingtona
EP3814345B8 (en) 2018-06-27 2024-10-30 PTC Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
EP3814360B8 (en) 2018-06-27 2024-11-06 PTC Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
WO2020231977A1 (en) 2019-05-13 2020-11-19 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
BR112021025655A2 (pt) * 2019-06-19 2022-02-01 Viiv Healthcare Uk No 5 Ltd Inibidores da replicação do vírus da imunodeficiência humana
CN115151540A (zh) 2019-12-02 2022-10-04 风暴治疗有限公司 作为mettl3抑制剂的多杂环化合物
CN114751902B (zh) * 2021-01-08 2024-11-22 正大天晴药业集团股份有限公司 一种4H-吡啶并[1,2-a]嘧啶-4-酮化合物的制备方法
AU2024312352A1 (en) * 2023-06-19 2025-12-11 F. Hoffmann-La Roche Ag Trem2 agonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2572030T3 (es) * 2001-08-10 2017-07-19 Shionogi & Co., Ltd. Agente antiviral
TW200526635A (en) * 2003-12-22 2005-08-16 Shionogi & Co Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
US7273859B2 (en) * 2004-05-12 2007-09-25 Bristol-Myers Squibb Company HIV integrase inhibitors: cyclic pyrimidinone compounds
US7939537B2 (en) * 2005-10-04 2011-05-10 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. HIV integrase inhibitors
JP2008019644A (ja) 2006-07-13 2008-01-31 Hitoshi Koide 石油または天然ガスの増進回収方法及びその増進回収システム
JP5208962B2 (ja) * 2006-12-22 2013-06-12 アベキサ・リミテッド 二環式ピリミジノンおよびその使用
JP5592360B2 (ja) 2008-07-02 2014-09-17 アベキサ・リミテッド イミダゾピリミジノンおよびその使用

Also Published As

Publication number Publication date
NZ590126A (en) 2012-11-30
MX2011000149A (es) 2011-02-24
JP2011526248A (ja) 2011-10-06
EP2212324A1 (en) 2010-08-04
JP5535204B2 (ja) 2014-07-02
IL210207A0 (en) 2011-03-31
EP2759544A1 (en) 2014-07-30
ES2459046T3 (es) 2014-05-07
CN102143962A (zh) 2011-08-03
CN102143962B (zh) 2015-03-11
AU2009266421B2 (en) 2013-07-11
EP2212324A4 (en) 2011-01-19
BRPI0913934A2 (pt) 2015-10-20
US20130059865A1 (en) 2013-03-07
AU2009266421A1 (en) 2010-01-07
US20110039842A1 (en) 2011-02-17
US8563562B2 (en) 2013-10-22
EP2212324B1 (en) 2014-03-26
WO2010000032A1 (en) 2010-01-07
SG192452A1 (en) 2013-08-30
US8318732B2 (en) 2012-11-27
CA2729663A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
IL210207A0 (en) Compounds having antiviral properties
AP2874A (en) Antiviral compounds
IL202623A0 (en) Antiviral compounds
GB0800035D0 (en) Compounds
IL213167A0 (en) Purine compounds
EP2234623A4 (en) ANTIVIRAL CONNECTIONS
GB0804702D0 (en) Compounds
GB0800367D0 (en) Compounds
GB0801220D0 (en) Compounds
GB0801265D0 (en) Compounds
IL192335A0 (en) Antiviral compounds
GB0819528D0 (en) Antiviral compounds
GB0816600D0 (en) Antiviral compounds
AU2008903407A0 (en) Compounds having antiviral properties
ZA201000662B (en) Antiviral compounds
GB0800841D0 (en) Compounds
GB0803496D0 (en) Compounds
GB0801219D0 (en) Compounds
GB0800455D0 (en) Compounds
GB0800454D0 (en) Compounds
GB0801596D0 (en) Compounds
GB0802191D0 (en) Compounds
GB0802192D0 (en) Compounds
GB0802231D0 (en) Compounds
GB0802586D0 (en) Compounds